Basic Information
LACOSAMIDE
50228-192
Regulatory Information
50228-192
ANDA205237
C73584
January 9, 2023
USA
These highlights do not include all the information needed to use LACOSAMIDE TABLETS safely and effectively. See full prescribing information for LACOSAMIDE TABLETS . LACOSAMIDE tablets, film coated tablet, for oral use, CV Initial U.S. Approval: 2008
HUMAN PRESCRIPTION DRUG LABEL
3
Company Information
079391286
Active Ingredients
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
CROSPOVIDONE
Code: 2S7830E561
Class Code: IACT
HYPROMELLOSE 2910 (6 MPA.S)
Code: 0WZ8WG20P6
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
FD&C BLUE NO. 2
Code: L06K8R7DQK
Class Code: IACT
FD&C RED NO. 40
Code: WZB9127XOA
Class Code: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIED
Code: 9XZ8H6N6OH
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
Active Moieties
LACOSAMIDE
Code: 563KS2PQY5